The influence of genetic variants of sorafenib on clinical outcomes and toxic effects in patients with advanced renal cell carcinomaChao Qin, Changjun Yin, Jian Wang et al.|Scientific Reports|2016Cited by 31
Significance of cyclooxygenase‑2, prostaglandin E2 and CD133 levels in sunitinib‑resistant renal cell carcinomaLei Luo, Lijiang Sun|Oncology Letters|2019Cited by 15
Obesity is a predictor in prostate cancer patients receiving prostatectomy after neoadjuvant hormonal therapyLijiang Sun, Guiming Zhang, Ting Xu et al.|Tumori Journal|2019Cited by 2